L. Edwards

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

P. Nyirjesy, J. Sobel, S. Filler, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cell-free DNA screening for trisomies 21, 18 and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.

S. Haeri, F. Malone, M. Rabinowitz, 2022, American journal of obstetrics and gynecology.

Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome.

S. Haeri, F. Malone, M. Rabinowitz, 2022, American journal of obstetrics and gynecology.

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

Michael Dallas, N. Sardesai, D. Weiner, 2015, The Lancet.

67 Multicenter prospective study of SNP-based cfDNA for 22q11.2 deletion in 18,289 pregnancies with genetic confirmation

S. Haeri, F. Malone, B. Jacobsson, 2021 .

Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.

J. Koo, D. Piacquadio, L. Edwards, 1998, Clinical therapeutics.